TMCnet News

Amicus Therapeutics to Present at the 4th Annual Evercore ISI HealthCONx Virtual Conference
[November 24, 2021]

Amicus Therapeutics to Present at the 4th Annual Evercore ISI HealthCONx Virtual Conference


PHILADELPHIA, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the 4th Annual Evercore ISI HealthCONx Virtual Conference on Wednesday, December 1, 2021 at 8:50 a.m. E.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living ith rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn.



CONTACT:

Investors:
Andrew Faughnan
Executive Director, Investor Relations
[email protected]
(609) 662-3809


Media:
Diana Moore
Head of Global Corporate Affairs & Communications
[email protected]
(609) 662-5079

FOLD–G


Primary Logo


[ Back To TMCnet.com's Homepage ]